Thomas Kester - InspireMD Director
| NSPR Stock | USD 1.95 0.01 0.52% |
Director
Mr. Thomas J. Kester, CPA, was appointed as Director of the Company since 2016.
| Age | 68 |
| Tenure | 8 years |
| Professional Marks | MBA |
| Address | 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832 |
| Phone | 972 3 6917691 |
| Web | https://www.inspiremd.com |
InspireMD Management Efficiency
The company has return on total asset (ROA) of (0.3656) % which means that it has lost $0.3656 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7001) %, meaning that it created substantial loss on money invested by shareholders. InspireMD's management efficiency ratios could be used to measure how well InspireMD manages its routine affairs as well as how well it operates its assets and liabilities. As of 05/01/2024, Return On Tangible Assets is likely to drop to -0.44. In addition to that, Return On Capital Employed is likely to drop to -0.53. At this time, InspireMD's Total Assets are relatively stable compared to the past year. As of 05/01/2024, Total Current Assets is likely to grow to about 46.4 M, while Non Currrent Assets Other are likely to drop slightly above 654.2 K.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| William Petrie | Acadia Healthcare | 71 | |
| NancyAnn DeParle | HCA Holdings | 64 | |
| Wayne Riley | HCA Holdings | 61 | |
| John Rowe | HCA Holdings | 72 | |
| Wade Miquelon | Acadia Healthcare | 53 | |
| Jay Light | HCA Holdings | 74 | |
| William Frist | HCA Holdings | 51 | |
| Geoffrey Meyers | HCA Holdings | 73 | |
| Reeve Waud | Acadia Healthcare | 54 | |
| Michael Gaynor | Novo Integrated Sciences | 49 | |
| EPerot Bissell | Acadia Healthcare | 58 | |
| Charles Holliday | HCA Holdings | 73 | |
| Meg Crofton | HCA Holdings | 67 | |
| Ann Lamont | HCA Holdings | 58 | |
| Chris Gordon | Acadia Healthcare | 44 | |
| Michael Michelson | HCA Holdings | 69 | |
| Kyle Lattner | Acadia Healthcare | 29 | |
| Christopher Gordon | Acadia Healthcare | 44 | |
| Annie Lamont | HCA Holdings | 60 | |
| Vicky Gregg | Acadia Healthcare | 63 | |
| Robert Dennis | HCA Holdings | 67 | |
Management Performance
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.37 |
InspireMD Leadership Team
Elected by the shareholders, the InspireMD's board of directors comprises two types of representatives: InspireMD inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InspireMD. The board's role is to monitor InspireMD's management team and ensure that shareholders' interests are well served. InspireMD's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InspireMD's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James Loughlin, Independent Director | ||
| Roei Samuri, VP Operations | ||
| Eli Bar, Senior Vice President - Research and Development and Chief Technical Officer of InspireMD Ltd | ||
| Craig Shore, CFO, Chief Admin. Officer, Secretary and Treasurer | ||
| Campbell Rogers, Independent Director | ||
| Michael Berman, Independent Director | ||
| Marvin Slosman, CEO President | ||
| Sol Barer, Independent Chairman of the Board | ||
| Alan Milinazzo, CEO and President and Director | ||
| Agustin Gago, Executive Vice President Chief Commercial Officer | ||
| Shane Gleason, Chief Officer | ||
| Thomas Kester, Director | ||
| Isaac Blech, Vice Chairman of the Board | ||
| DVM MD, Executive Affairs | ||
| Andrea Tommasoli, Chief Officer | ||
| Amir Kohen, Vice Resources | ||
| Pete Ligotti, Executive America | ||
| Paul Stuka, Independent Director | ||
| James Barry, COO, Executive VP and Director |
InspireMD Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InspireMD a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.37 | ||||
| Operating Margin | (3.30) % | ||||
| Current Valuation | 7.85 M | ||||
| Shares Outstanding | 23.42 M | ||||
| Shares Owned By Insiders | 20.18 % | ||||
| Shares Owned By Institutions | 43.16 % | ||||
| Number Of Shares Shorted | 92.69 K | ||||
| Price To Earning | (0.16) X | ||||
| Price To Book | 1.38 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InspireMD in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InspireMD's short interest history, or implied volatility extrapolated from InspireMD options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for InspireMD Stock analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is InspireMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InspireMD. If investors know InspireMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InspireMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.82) | Revenue Per Share 0.256 | Quarterly Revenue Growth 0.716 | Return On Assets (0.37) | Return On Equity (0.70) |
The market value of InspireMD is measured differently than its book value, which is the value of InspireMD that is recorded on the company's balance sheet. Investors also form their own opinion of InspireMD's value that differs from its market value or its book value, called intrinsic value, which is InspireMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InspireMD's market value can be influenced by many factors that don't directly affect InspireMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InspireMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if InspireMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InspireMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.